MRSN
Price
$0.29
Change
-$0.03 (-9.38%)
Updated
Jun 27 closing price
Capitalization
36.27M
37 days until earnings call
NRIX
Price
$11.64
Change
+$0.02 (+0.17%)
Updated
Jun 27 closing price
Capitalization
887.38M
10 days until earnings call
Interact to see
Advertisement

MRSN vs NRIX

Header iconMRSN vs NRIX Comparison
Open Charts MRSN vs NRIXBanner chart's image
Mersana Therapeutics
Price$0.29
Change-$0.03 (-9.38%)
Volume$15.83M
Capitalization36.27M
Nurix Therapeutics
Price$11.64
Change+$0.02 (+0.17%)
Volume$2.06M
Capitalization887.38M
MRSN vs NRIX Comparison Chart in %
Loading...
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRSN vs. NRIX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRSN is a Buy and NRIX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (MRSN: $0.29 vs. NRIX: $11.64)
Brand notoriety: MRSN and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRSN: 556% vs. NRIX: 248%
Market capitalization -- MRSN: $36.27M vs. NRIX: $887.38M
MRSN [@Biotechnology] is valued at $36.27M. NRIX’s [@Biotechnology] market capitalization is $887.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRSN’s FA Score shows that 0 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • MRSN’s FA Score: 0 green, 5 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, NRIX is a better buy in the long-term than MRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRSN’s TA Score shows that 4 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • MRSN’s TA Score: 4 bullish, 5 bearish.
  • NRIX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both MRSN and NRIX are a bad buy in the short-term.

Price Growth

MRSN (@Biotechnology) experienced а -20.47% price change this week, while NRIX (@Biotechnology) price change was +1.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

MRSN is expected to report earnings on Aug 06, 2025.

NRIX is expected to report earnings on Jul 10, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($887M) has a higher market cap than MRSN($36.3M). NRIX YTD gains are higher at: -38.217 vs. MRSN (-79.650). MRSN has higher annual earnings (EBITDA): -68.42M vs. NRIX (-214M). NRIX has more cash in the bank: 550M vs. MRSN (102M). MRSN has less debt than NRIX: MRSN (24.6M) vs NRIX (26.6M). NRIX has higher revenues than MRSN: NRIX (56.4M) vs MRSN (34M).
MRSNNRIXMRSN / NRIX
Capitalization36.3M887M4%
EBITDA-68.42M-214M32%
Gain YTD-79.650-38.217208%
P/E RatioN/AN/A-
Revenue34M56.4M60%
Total Cash102M550M19%
Total Debt24.6M26.6M92%
FUNDAMENTALS RATINGS
MRSN: Fundamental Ratings
MRSN
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MRSNNRIX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 14 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
87%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
MRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BELFA88.403.81
+4.50%
Bel Fuse
LTRN3.180.04
+1.27%
Lantern Pharma
SE159.310.80
+0.50%
Sea Limited
FRSH14.82N/A
N/A
Freshworks
NOTV1.70-0.14
-7.61%
Inotiv

MRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRSN has been loosely correlated with IGMS. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if MRSN jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRSN
1D Price
Change %
MRSN100%
-10.46%
IGMS - MRSN
57%
Loosely correlated
N/A
CRNX - MRSN
49%
Loosely correlated
-0.10%
DYN - MRSN
46%
Loosely correlated
-4.78%
DNLI - MRSN
44%
Loosely correlated
-2.69%
NRIX - MRSN
42%
Loosely correlated
+0.17%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been closely correlated with KYMR. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+0.17%
KYMR - NRIX
67%
Closely correlated
-3.48%
DNLI - NRIX
59%
Loosely correlated
-2.69%
IDYA - NRIX
58%
Loosely correlated
-4.13%
RNA - NRIX
55%
Loosely correlated
-2.68%
BEAM - NRIX
55%
Loosely correlated
-1.98%
More